Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woo, Young Sup | - |
dc.contributor.author | Bahk, Won-Myong | - |
dc.contributor.author | Jon, Duk-In | - |
dc.contributor.author | Joo, Yeon Ho | - |
dc.contributor.author | Kim, Won | - |
dc.contributor.author | Seo, Jeong Seok | - |
dc.contributor.author | Ahn, Yong Min | - |
dc.contributor.author | Chung, Sang-Keun | - |
dc.contributor.author | Won, Seung-Hee | - |
dc.contributor.author | Shin, Young Chul | - |
dc.contributor.author | Yoon, Bo-Hyun | - |
dc.contributor.author | Jung, Sung-Hun | - |
dc.contributor.author | Seok, Jeong Ho | - |
dc.contributor.author | Lee, Yil-Seob | - |
dc.contributor.author | Kim, Yooni | - |
dc.contributor.author | Min, Kyung Joon | - |
dc.date.accessioned | 2022-01-06T02:42:41Z | - |
dc.date.available | 2022-01-06T02:42:41Z | - |
dc.date.issued | 2009-10 | - |
dc.identifier.issn | 0278-5846 | - |
dc.identifier.issn | 1878-4216 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/52932 | - |
dc.description.abstract | The goal of this study was to assess the incidence of rash occurring in patients received lamotrigine to treat bipolar I disorder in a real world setting in Korea. We included a heterogeneous sample with multiple medications and medical comorbidities. Lamotrigine was added to the current therapy regime for DSM-IV bipolar I patients on an open-label basis for 12 weeks. The incidences of rash and other adverse events were assessed. The primary outcome measure was the incidence of rash. A total of 237 adult patients were included in the present study and 173 patients (73.0%) completed the 12 weeks of treatment. Thirty patients (12.7%) developed a rash, of whom 2 (0.8%) developed a serious rash. There were no patients who developed Stevens-Johnson syndrome or toxic epidermal necrolysis. The median time of rash onset was 16 days. As a group, patients who did not experience rash were significantly heavier than those who did. Our findings suggest that the incidence of serious rash associated with lamotrigine is low. The prescription of lamotrigine should be undertaken with appropriate consideration of the potential risk of adverse events including rash to the patient in relation to potential benefit from improvement of bipolar disorder. (C) 2009 Published by Elsevier Inc. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: A multicenter, prospective, naturalistic, open-label trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.pnpbp.2009.06.010 | - |
dc.identifier.bibliographicCitation | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.33, no.7, pp 1147 - 1152 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000270285500008 | - |
dc.identifier.scopusid | 2-s2.0-69549109983 | - |
dc.citation.endPage | 1152 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 1147 | - |
dc.citation.title | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | - |
dc.citation.volume | 33 | - |
dc.type.docType | Article; Proceedings Paper | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Bipolar I disorder | - |
dc.subject.keywordAuthor | Lamotrigine | - |
dc.subject.keywordAuthor | Rash | - |
dc.subject.keywordPlus | LITHIUM MAINTENANCE TREATMENT | - |
dc.subject.keywordPlus | CONTROLLED 18-MONTH TRIAL | - |
dc.subject.keywordPlus | WEEKLY SYMPTOMATIC STATUS | - |
dc.subject.keywordPlus | STEVENS-JOHNSON-SYNDROME | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | POPULATION PHARMACOKINETICS | - |
dc.subject.keywordPlus | MONOTHERAPY | - |
dc.subject.keywordPlus | EPILEPSY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | GABAPENTIN | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.